BIO-ENGINEERED STENT MARKET ANALYSIS

Bio-engineered Stent Market, by Application Type (Coronary Artery Disease, Peripheral Arterial Disease, Carotid Artery Disease, Renal Artery Stenosis, Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm, Others), by Product Type (Drug-eluting Stents, Bioabsorbable Stents, and Drug-eluting Balloons), by Mode of Delivery (Balloon-expandable Stents and Self-expanding Stents), by Material Type (Metal-based and Polymer-based), by End User (Hospitals & Cardiac Centers and Ambulatory Surgical Centers, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Industry Insights and Forecast to 2026

Published In : Feb 2019
Code : CMI2484
Pages :176
Formats :
Excel and PDF
Industry : Medical Devices

Leading Companies

Key Players

Major players operating in the global bio-engineered stent market include, Medtronic, plc., Boston Scientific Corporation, Abbott Laboratories, Biotronik SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, MicroPort Scientific Corporation, Stentys Sao, Meril Life Sciences Pvt. Ltd, Vascular Concepts, W. L. Gore and Associates, C. R. Bard, Endologix, Inc., Lombard Medical Technologies, Translumina GmbH, and JOTEC GmbH.

Bio-engineered Stent Market Report Snapshots